stars 1 stars 2 stars 3

H3 Biomedicine is a privately held biopharmaceutical company focused on the discovery and early development of novel, targeted anti-cancer compounds for the unmet needs of genetically defined patient populations. H3 has leveraged its integrated expertise in genomics, tumor biology, bioinformatics and innovative synthetic organic chemistry to create an integrated drug development ecosystem to deliver patient-based, genomics-driven, small molecule drugs. In less than three years, H3 has developed four discovery platforms, which have produced two drug candidates for which the company expects to file investigational new drug (IND) applications in late 2015. Founded by a $200 million dollar investment from Eisai Inc., and given operational and strategic independence, H3 has delivered on Eisai’s confidence with multiple platforms generating multiple lead programs. Having reached this inflection point, H3 is considering additional collaborators to fully realize the potential of its growing pipeline of lead programs and drug candidates. H3 Biomedicine operates in the spirit of the collaboration and camaraderie encouraged by our corporate culture. Each team member has a unique role to play in the quest to develop new cancer drugs. H3 Biomedicine employees are dedicated and passionate individuals who recognize that our potential as a team is much greater than if any one of us was working alone.

View Top Employees from H3 Biomedicine
Revenue $22 million
Employees 57 (57 on RocketReach)
Founded 2011
Address 300 Technology Square Floor 5, Cambridge, Massachusetts 02139-3520, US
Phone (617) 252-5000
Fax (617) 252-5098
JavaScript, HTML, G Suite +36 more (view full list)
Category Pharmaceutical Manufacturing, Biotechnology, Biopharmaceuticals, Pharmaceuticals, Oncology Treatment, Healthcare, Cancer Treatment, Cancer Research, Human Genetics, Synthetic Chemistry, Cancer Genomics, Tumor Biology, Bioinformatics, Small Molecule Drugs
Web Rank 3 Million
Keywords cso cambridge oncology, h3 biomedicine, h3biomedicine contact, h3 bio, h3 biomedicine inc
SIC 283, 28
NAICS 32, 325, 3254, 32541

H3 Biomedicine Questions

The H3 Biomedicine annual revenue was $22 million in 2023.

Douglas McMillin is the Senior Director Business Development of H3 Biomedicine.

57 people are employed at H3 Biomedicine.

H3 Biomedicine is based in Cambridge, Massachusetts.

The NAICS codes for H3 Biomedicine are [32, 325, 3254, 32541].

The SIC codes for H3 Biomedicine are [283, 28].

Get Verified Emails for 57 H3 Biomedicine Employees

{{numFreeLookups}} free lookups per month. No credit card required.

The most common H3 Biomedicine email format is [first]_[last] (ex., which is being used by 94.9% of H3 Biomedicine work email addresses.

Other common H3 Biomedicine email patterns are [first] (ex. In all, H3 Biomedicine uses 2 work email formats.

H3 Biomedicine Email Formats and Examples

Email Format Example Percentage

Lorem ipsum dolor sit amet consectetur adipisicing elit.

Lorem ipsum dolor sit amet

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
G2Crowd Trusted
300K+ Plugin Users